(Q43746684)

26 November 2017

Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease (English)

1 reference

26 November 2017

1 reference

1 reference

6

1 reference

26 November 2017

Sakakibara R

1

1 reference

26 November 2017

Shinotoh H

2

1 reference

26 November 2017

Uchiyama T

3

1 reference

26 November 2017

Sakuma M

4

1 reference

26 November 2017

Kashiwado M

5

1 reference

26 November 2017

Hattori T

7

1 reference

26 November 2017

1 September 2001

1 reference

Autonomic Neuroscience: Basic and Clinical

26 November 2017

1 reference

26 November 2017

92

1 reference

26 November 2017

1-2

1 reference

26 November 2017

76-85

1 reference

Disturbances of bladder and urethral function in Parkinson's disease

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Physiology of penile erection

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Effects of apomorphine and L-dopa on the parkinsonian bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Manometric investigation of anorectal function in early and late stage Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Effect of levodopa on urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Urodynamic findings in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Sexual function and affect in parkinsonian men treated with L-dopa

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Sexual function in patients with Parkinson's disease and their partners

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Effect of age at onset on progression and mortality in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Gastrointestinal symptoms in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Defecatory function in Parkinson's disease: response to apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Micturition disturbance in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Urethral sphincter abnormalities in Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Lower urinary tract dysfunction in Parkinson's disease: changes relate to age and not disease

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Prevalence, 1-year incidence and factors associated with urinary incontinence: a population based study of women 50-74 years of age in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Gender differences in sexual activity among mid-aged adults in Massachusetts.

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Sexual dysfunction in the United States: prevalence and predictors

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Extrapyramidal inhibition of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Sexual function in married men with Parkinson's disease compared to married men with arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Urinary incontinence and lower urinary tract symptoms: an epidemiological study of men aged 45 to 99 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Constipation and paradoxical puborectalis contraction in anismus and Parkinson's disease: a dystonic phenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Urinary function in elderly people with and without leukoaraiosis: relation to cognitive and gait function

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

What contributes to quality of life in patients with Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

1 reference

7 January 2021

Regulation of masculine sexual behavior: involvement of brain opioids and dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Sexuality in women with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.

1 reference

https://api.crossref.org/works/10.1016%2FS1566-0702%2801%2900295-8

7 January 2021

10.1016/S1566-0702(01)00295-8

Identifiers

DOI

1 reference

26 November 2017

1 reference